PF4 and transitional cell carcinoma: Likewise, PF4 (platelet factor 4) inhibits tumor growth and metastasis by suppressing neovascularization [56], consistent with the positive association we found between PF4 methylation and later urothelial cell carcinoma (Fig. 7g).